101 related articles for article (PubMed ID: 6349531)
1. [Studies on the mechanism of cytotoxicity of 5-fluorouracil--through impairment of metabolism].
Ikenaka K; Tanaka H; Kawai K; Shirasaka T; Fujii S
Gan To Kagaku Ryoho; 1983 Feb; 10(2 Pt):227-31. PubMed ID: 6349531
[TBL] [Abstract][Full Text] [Related]
2. [Correlation of mitochondrial ribonucleotide reductase and thymidine kinase activities with the synthesis of mitochondrial DNA in rat liver during regeneration].
Danilova NI; Silaeva SA; Debov SS
Biokhimiia; 1977 Nov; 42(11):1973-7. PubMed ID: 588631
[TBL] [Abstract][Full Text] [Related]
3. Metabolism of 5-fluorouracil in sensitive and resistant tumor cells.
Fukushima M; Ikenaka K; Shirasaka T; Fujii S
Gan; 1979 Feb; 70(1):47-53. PubMed ID: 556350
[TBL] [Abstract][Full Text] [Related]
4. Interferon and the incorporation of 5-fluorouracil into RNA of normal tissues and a secondary liver carcinoma in rat.
Roos G; Stenram U
Anticancer Res; 1994; 14(2A):379-82. PubMed ID: 7517119
[TBL] [Abstract][Full Text] [Related]
5. Effect of 5-fluorouracil on the release of thymidine kinase from hepatoma cells in vitro.
Taylor A; Jones OW; Grishaver MA
Cancer Res; 1981 Jan; 41(1):192-6. PubMed ID: 7448759
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-2 as a modulator of 5-fluorouracil in hepatic arterial immunochemotherapy for liver metastases.
Okuno K; Hirai N; Takemoto Y; Kawai I; Yasutomi M
Hepatogastroenterology; 2000; 47(32):487-91. PubMed ID: 10791219
[TBL] [Abstract][Full Text] [Related]
7. [Experimental study of the combined effect of 5-fluorouracil and cyclophosphane on growth of Zajdela hepatoma and nucleic acid metabolism].
Reztsova VV; Stukov AN; Filov VA
Biull Eksp Biol Med; 1980 Oct; 90(10):469-71. PubMed ID: 7426710
[TBL] [Abstract][Full Text] [Related]
8. The target cell determinants of the antitumor actions of 5-FU: does FU incorporation into RNA play a role?
Mandel HG
Cancer Treat Rep; 1981; 65 Suppl 3():63-71. PubMed ID: 6179616
[TBL] [Abstract][Full Text] [Related]
9. [Nuclear ribonucleotide reductase of cells of normal regenerating liver and sarcoma M-1 in rats].
Shermet'evskaia TN; Silaeva SA; Khatsernova BIa; Debov SS
Vopr Med Khim; 1974; 20(4):430-5. PubMed ID: 4462297
[No Abstract] [Full Text] [Related]
10. Cytotoxic effects and mechanisms of an alteration in the dose and duration of 5-fluorouracil.
Patel M; Ardalan K; Hochman I; Tian EM; Ardalan B
Anticancer Res; 2003; 23(1A):447-52. PubMed ID: 12680247
[TBL] [Abstract][Full Text] [Related]
11. [Mechanism of action of anti-cancer drugs from the viewpoint of RNA metabolism].
Kanamaru R; Wakui A
Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 2-1):1011-8. PubMed ID: 3291764
[TBL] [Abstract][Full Text] [Related]
12. [The mechanism of potentiation of the antitumor effect of 5-fluorouracil by methionine-free intravenous amino acid solution (AO-90) in rats].
Hibino Y; Kawarabayashi Y; Kohri H; Ueda N; Tsukagoshi S
Gan To Kagaku Ryoho; 1994 Sep; 21(12):2021-8. PubMed ID: 8085853
[TBL] [Abstract][Full Text] [Related]
13. An update on the biochemistry of 5-fluorouracil.
Ardalan B; Glazer R
Cancer Treat Rev; 1981 Sep; 8(3):157-67. PubMed ID: 6272993
[No Abstract] [Full Text] [Related]
14. [Structure and biosynthetic functions of rat liver mitochondrial fractions].
Golubev VP; Kozel'tsev VL; Silaeva SA
Vopr Med Khim; 1980; 26(3):312-8. PubMed ID: 6256957
[TBL] [Abstract][Full Text] [Related]
15. [Changes in the replication apparatus and phosphorus-containing metabolite pool in experimental tumors in animals during development].
Gorbacheva LB; Gudtsova KV; Dederer LIu; Sokolova IS; Sibel'dina LA; Shkarin PIu
Vopr Med Khim; 1991; 37(6):33-6. PubMed ID: 1812611
[TBL] [Abstract][Full Text] [Related]
16. Modulation of 5-fluorouracil toxicity by uridine, deoxyuridine, orotate and dipyridamole in normal tissues of rats with liver adenocarcinoma.
el Hag IA; Jakobsson B; Christensson PI; Erichsen C; Jönsson PE; Stenram U
In Vivo; 1987; 1(5):309-12. PubMed ID: 2485133
[TBL] [Abstract][Full Text] [Related]
17. Mechanism of action of a new antitumor ribonucleoside, 1-(3-C-ethynyl-beta-D-ribo-pentofuranosyl)cytosine (ECyd, TAS-106), differs from that of 5-fluorouracil.
Kazuno H; Shimamoto Y; Tsujimoto H; Fukushima M; Matsuda A; Sasaki T
Oncol Rep; 2007 Jun; 17(6):1453-60. PubMed ID: 17487404
[TBL] [Abstract][Full Text] [Related]
18. [Changes in the activity of thymidine kinase, ribonucleotide reductase and DNA-polymerases during the development of leukemia P388 in mice].
Dederer LIu; Sokolova IS; Gudtsova KV; Gorbacheva LB
Dokl Akad Nauk SSSR; 1990; 313(1):219-22. PubMed ID: 2090418
[No Abstract] [Full Text] [Related]
19. Biochemical modulation of 5-fluorouracil with interferon alpha/beta and gamma on murine renal cell carcinoma.
Ishii T; Marumo K
Int J Urol; 2004 Nov; 11(11):993-1000. PubMed ID: 15509204
[TBL] [Abstract][Full Text] [Related]
20. Incorporation of 5-fluorouracil into RNA of normal tissues and an adenocarcinoma in protein-deprived rats.
el Hag IA; Jakobsson B; Erichsen C; Christensson PI; Jönsson PE; Stenram U
In Vivo; 1987; 1(4):215-20. PubMed ID: 2485132
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
